These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
196 related articles for article (PubMed ID: 16514114)
1. Fibrin derived from patients with chronic thromboembolic pulmonary hypertension is resistant to lysis. Morris TA; Marsh JJ; Chiles PG; Auger WR; Fedullo PF; Woods VL Am J Respir Crit Care Med; 2006 Jun; 173(11):1270-5. PubMed ID: 16514114 [TBL] [Abstract][Full Text] [Related]
2. Fibrin resistance to lysis in patients with pulmonary hypertension other than thromboembolic. Miniati M; Fiorillo C; Becatti M; Monti S; Bottai M; Marini C; Grifoni E; Formichi B; Bauleo C; Arcangeli C; Poli D; Nassi PA; Abbate R; Prisco D Am J Respir Crit Care Med; 2010 May; 181(9):992-6. PubMed ID: 20075386 [TBL] [Abstract][Full Text] [Related]
3. [Measurements of plasmin-alpha 2 plasmin inhibitor complex and FDP.D dimer levels in the fibrinolytic therapy of acute pulmonary thromboembolism]. Yamasawa F; Hasegawa N; Asano K; Sayama K; Fujita H; Urano T; Aoki T; Ishizaka A; Kanazawa M; Kawashiro T Kokyu To Junkan; 1992 Jul; 40(7):685-90. PubMed ID: 1387724 [TBL] [Abstract][Full Text] [Related]
4. Incorporation of fragment X into fibrin clots renders them more susceptible to lysis by plasmin. Schaefer AV; Leslie BA; Rischke JA; Stafford AR; Fredenburgh JC; Weitz JI Biochemistry; 2006 Apr; 45(13):4257-65. PubMed ID: 16566600 [TBL] [Abstract][Full Text] [Related]
5. Post-thrombolysis haemostasis changes after rt-PA treatment in acute cerebral infarct. Correlations with cardioembolic aetiology and outcome. Sun X; Berthiller J; Derex L; Trouillas P; Diallo L; Hanss M J Neurol Sci; 2015 Feb; 349(1-2):77-83. PubMed ID: 25619569 [TBL] [Abstract][Full Text] [Related]
6. Cleavage of surfactant-incorporating fibrin by different fibrinolytic agents. Kinetics of lysis and rescue of surface activity. Günther A; Markart P; Kalinowski M; Ruppert C; Grimminger F; Seeger W Am J Respir Cell Mol Biol; 1999 Dec; 21(6):738-45. PubMed ID: 10572071 [TBL] [Abstract][Full Text] [Related]
7. Molecular mechanisms of fibrinolysis and their application to fibrin-specific thrombolytic therapy. Collen D J Cell Biochem; 1987 Feb; 33(2):77-86. PubMed ID: 3553213 [TBL] [Abstract][Full Text] [Related]
8. Fluorogenic fibrinogen and fibrin facilitate macromolecular assembly and dynamic assay of picomolar levels of plasminogen activators under well mixed conditions. Wu JH; Diamond SL Thromb Haemost; 1995 Aug; 74(2):711-7. PubMed ID: 8585011 [TBL] [Abstract][Full Text] [Related]
9. Acyl-enzymes as thrombolytic agents in dog models of venous thrombosis and pulmonary embolism. Dupe RJ; English PD; Smith RA; Green J Thromb Haemost; 1984 Apr; 51(2):248-53. PubMed ID: 6234676 [TBL] [Abstract][Full Text] [Related]
10. Fibrinolysis and thrombosis of fibrinogen-modified gold nanoparticles for detection of fibrinolytic-related proteins. Jian JW; Chiu WC; Chang HT; Hsu PH; Huang CC Anal Chim Acta; 2013 Apr; 774():67-72. PubMed ID: 23567118 [TBL] [Abstract][Full Text] [Related]
11. Hyperhomocysteinemia in patients with pulmonary embolism is associated with impaired plasma fibrinolytic capacity. Cellai AP; Lami D; Antonucci E; Liotta AA; Rogolino A; Fedi S; Fiorillo C; Becatti M; Cenci C; Marcucci R; Abbate R; Prisco D J Thromb Thrombolysis; 2014 Jul; 38(1):45-9. PubMed ID: 23963720 [TBL] [Abstract][Full Text] [Related]
13. Decreased plasmin resistance by clots of a homophenotypic Aalpha R 16H fibrinogen (Kingsport, slower fibrinopeptide A than fibrinopeptide B release). Galanakis DK; Neerman-Arbez M; Kudryk B; Henschen A Blood Coagul Fibrinolysis; 2010 Mar; 21(2):135-9. PubMed ID: 20019599 [TBL] [Abstract][Full Text] [Related]
14. Mechanism of ancrod anticoagulation. A direct proteolytic effect on fibrin. Pizzo SV; Schwartz ML; Hill RL; McKee PA J Clin Invest; 1972 Nov; 51(11):2841-50. PubMed ID: 4263497 [TBL] [Abstract][Full Text] [Related]
15. Nephelometric determination of plasminogen and plasmin inhibitors in human plasma using fibrin suspension as a substrate. Saito Y; Takabayashi K; Tsukada T; Inada Y Thromb Res; 1983 Apr; 30(1):47-54. PubMed ID: 6222510 [TBL] [Abstract][Full Text] [Related]
16. Molecular basis of fibrinolysis, as relevant for thrombolytic therapy. Collen D; Lijnen HR Thromb Haemost; 1995 Jul; 74(1):167-71. PubMed ID: 8578451 [TBL] [Abstract][Full Text] [Related]
17. The influence of age on in vitro plasmin generation in the presence of fibrin monomer. Parmar N; Mitchell LG; Berry LR; Andrew M; Chan AK Acta Haematol; 2006; 115(3-4):141-51. PubMed ID: 16549888 [TBL] [Abstract][Full Text] [Related]
18. Calcium modulates plasmin cleavage of the fibrinogen D fragment gamma chain N-terminus: mapping of monoclonal antibody J88B to a plasmin sensitive domain of the gamma chain. Odrljin TM; Rybarczyk BJ; Francis CW; Lawrence SO; Hamaguchi M; Simpson-Haidaris PJ Biochim Biophys Acta; 1996 Nov; 1298(1):69-77. PubMed ID: 8948490 [TBL] [Abstract][Full Text] [Related]
19. Analysis of plasmin generation and clot lysis of plasma fibrinogen purified from a heterozygous dysfibrinogenemia, BbetaGly15Cys (Hamamatsu II). Kamijyo Y; Hirota-Kawadobora M; Yamauchi K; Terasawa F; Honda T; Ikeya M; Okumura N Blood Coagul Fibrinolysis; 2009 Dec; 20(8):726-32. PubMed ID: 19809304 [TBL] [Abstract][Full Text] [Related]
20. Fibrin subunits in venous and arterial thromboembolism. Gaffney PJ; Brasher M; Lord K; Strachan CJ; Wilkinson AR; Kakkar VV; Scully MF Cardiovasc Res; 1976 Jul; 10(4):421-6. PubMed ID: 133759 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]